The agreement stipulates that projects will be co-selected, drawing on shared interests and areas of expertise.

A Japanese man working for Astellas Pharma Inc. in China was taken into custody by Chinese authorities, and it has now been ...

The Aspergillosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders.

Astellas Pharma's zolbetuximab – currently leading an expanding pack of drugs targeting claudin 18.2 – has shown efficacy in the first of a pair of phase 3 trials of gastric or ...

Japanese Ambassador to China Kenji Kanasugi met Monday with a Japanese citizen who has been detained in Beijing for about two years on suspicion of espionage, a Japanese government source said. The ...

Astellas Pharma and Yaskawa Electric Corporation formalized a development deal signed last year that will see the two Japanese companies invest 3.5 billion Yen ($30.5 million) into developing an ...

Astellas Pharma and Yaskawa have agreed to form a JV that will focus on developing a cell therapy product manufacturing platform.